MedPath

Humedix Co., Ltd.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet

Phase 3
Recruiting
Conditions
Crow's Feet
Interventions
Device: HMM1-022
First Posted Date
2024-05-24
Last Posted Date
2024-05-24
Lead Sponsor
Humedix Co., Ltd.
Target Recruit Count
171
Registration Number
NCT06428253
Locations
🇰🇷

Chung-Ang University Hospital, Seoul, Heukseok-ro, Dongjak-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath